Restoration of T Cell function in multi-drug resistant bacterial sepsis after interleukin-7, anti-PD-L1, and OX-40 administration

Frontline Science: Anti-PD-L1 protects against infection with common bacterial pathogens after burn injury

(2017) Naeem K. Patil et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Nivolumab plus interferon-γ in the treatment of intractable mucormycosis

(2017) David Grimaldi et al.   LANCET INFECTIOUS DISEASES

OX40: Structure and function – What questions remain?

(2017) Jane Willoughby et al.   MOLECULAR IMMUNOLOGY

Host-directed therapies for bacterial and viral infections

(2017) Stefan H. E. Kaufmann et al.   NATURE REVIEWS DRUG DISCOVERY

Advances in the understanding and treatment of sepsis-induced immunosuppression

(2017) Fabienne Venet et al.   Nature Reviews Nephrology

Antimicrobial Resistance

(2016) Hilary D. Marston et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Frontline Science: Defects in immune function in patients with sepsis are associated with PD-1 or PD-L1 expression and can be restored by antibodies targeting PD-1 or PD-L1

(2016) Andriani C. Patera et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Interleukin 7 immunotherapy improves host immunity and survival in a two-hit model of Pseudomonas aeruginosa pneumonia

(2016) Yuichiro Shindo et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Parallels between Cancer and Infectious Disease

(2014) Richard S. Hotchkiss et al.   NEW ENGLAND JOURNAL OF MEDICINE

Persistent Lymphopenia After Diagnosis of Sepsis Predicts Mortality

(2014) Anne M. Drewry et al.   SHOCK

Treatment of Progressive Multifocal Leukoencephalopathy With Interleukin 7

(2014) Karl B. Alstadhaug et al.   JAMA Neurology

Detection ofblaGES-5in Carbapenem-Resistant Kluyvera intermedia Isolates Recovered from the Hospital Environment

(2013) Vanessa B. Ribeiro et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antibiotic use and resistance in emerging economies: a situation analysis for Viet Nam

(2013) Kinh Van Nguyen et al.   BMC PUBLIC HEALTH

OX40 Is a Potent Immune-Stimulating Target in Late-Stage Cancer Patients

(2013) B. D. Curti et al.   CANCER RESEARCH

Combination therapy for carbapenem-resistant Gram-negative bacteria

(2013) Alexandre P Zavascki et al.   Expert Review of Anti-Infective Therapy

Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach

(2013) Richard S Hotchkiss et al.   LANCET INFECTIOUS DISEASES

IL-7 Restores Lymphocyte Functions in Septic Patients

(2012) F. Venet et al.   JOURNAL OF IMMUNOLOGY

Management of multidrug-resistant enterococcal infections

(2011) C.A. Arias et al.   CLINICAL MICROBIOLOGY AND INFECTION

Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure

(2011) Jonathan S. Boomer et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Risk of acquiring multidrug-resistant Gram-negative bacilli from prior room occupants in the intensive care unit

(2010) S. Nseir et al.   CLINICAL MICROBIOLOGY AND INFECTION

Interleukin-7 (IL-7) Treatment Accelerates Neutrophil Recruitment through    T-Cell IL-17 Production in a Murine Model of Sepsis

(2010) K. R. Kasten et al.   INFECTION AND IMMUNITY

IL-7 Promotes T Cell Viability, Trafficking, and Functionality and Improves Survival in Sepsis

(2010) J. Unsinger et al.   JOURNAL OF IMMUNOLOGY

Accuracy of American Thoracic Society/Infectious Diseases Society of America criteria in predicting infection or colonization with multidrug-resistant bacteria at intensive-care unit admission

(2009) S. Nseir et al.   CLINICAL MICROBIOLOGY AND INFECTION

PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis

(2009) X. Huang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA